Siemens Healthineers (Corindus): Telerobotic surgery pioneerSiemens Healthineers last year spent $1.1 billion to acquire Corindus Vascular Robotics and its robot-assisted device that is FDA-cleared for coronary and peripheral vascular procedures.
Corindus’ CorPath GRX vascular robotic system boasts robotic-assisted control of coronary guide catheters, guidewires and rapid exchange catheters — with sub-millimeter measurement and 1 mm movement for proper stent positioning.
The system has enabled Corindus to be a pioneer in telerobotic surgery. The company was recently the subject of a documentary reviewing the power and potential of 5G technology. Called “The Speed of Thought,” it documented the first transcontinental interventional procedure performed using Corindus’ CorPath system. (Listen to our most recent DeviceTalks Weekly, in which Corindus COO Doug Teany discusses how 5G could enable more remote surgeries.)